Inhibition of PAF-induced activation of human platelets by verapamil.

Epinephrine potentiates activation of human platelets by low density lipoproteins.

Activation of platelets by eosinophil granule proteins.

Binding of the products of prothrombin activation to human platelets.

Temperature-dependence of LDL binding and activation of human platelets.

Activation and inhibition of human alcohol dehydrogenase by monoclonal antibodies.

Inhibition of human platelet activation by polymorphonuclear leukocytes.

Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin.

In vitro inhibition by endothelins of thrombin-induced aggregation and Ca2+ mobilization in human platelets.

Activation of human platelets by platelet activating factor (PAF) derived from sensitized rabbit basophils.

Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.

Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.

Storage of human platelets by freezing.

Phagocytosis of liposomes by human platelets.

Shear-induced activation of platelets.

Activation of platelets by endocannabinoids: distinct agonists or arachidonate reservoirs?

Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.

Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.

Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets.

Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins.

Endothelial activation by platelets from sickle cell anemia patients.

Lipoxin generation by permeabilized human platelets.

Superoxide dismutase triggers activation of "primed" platelets.

Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts.

Inhibition of mouse skin tumor promotion by adriamycin and daunomycin in combination with verapamil or palmitoylcarnitine.

Suggest Documents

Epinephrine potentiates activation of human platelets by low density lipoproteins.

Activation of platelets by eosinophil granule proteins.

Binding of the products of prothrombin activation to human platelets.

Temperature-dependence of LDL binding and activation of human platelets.

Activation and inhibition of human alcohol dehydrogenase by monoclonal antibodies.

Inhibition of human platelet activation by polymorphonuclear leukocytes.

Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin.

In vitro inhibition by endothelins of thrombin-induced aggregation and Ca2+ mobilization in human platelets.

Activation of human platelets by platelet activating factor (PAF) derived from sensitized rabbit basophils.

Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.

Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.

Storage of human platelets by freezing.

Phagocytosis of liposomes by human platelets.

Shear-induced activation of platelets.

Activation of platelets by endocannabinoids: distinct agonists or arachidonate reservoirs?

Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.

Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.

Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets.

Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins.

Endothelial activation by platelets from sickle cell anemia patients.

Lipoxin generation by permeabilized human platelets.

Superoxide dismutase triggers activation of "primed" platelets.

Hydrocortisone inhibition of the bradykinin activation of human synovial fibroblasts.

Inhibition of mouse skin tumor promotion by adriamycin and daunomycin in combination with verapamil or palmitoylcarnitine.

Inhibition of PAF-induced activation of human platelets by verapamil.

Recommend Documents

Follow Us